Editor-in-Chief
Prof. Paul J. Higgins
is currently a Professor and Director of the Center for Cell Biology and Cancer Research at the Albany Medical College in Albany, New York. He was the founding Vice President of the Albany Research Institute (ARI) and currently serves on the ARI Board of Directors. He has received several prestigious awards including the Moyer Award and, most recently, the 2008 Excellence Award in Molecular Medicine. Molecular genetic studies in Dr. Higgins laboratory identified the mammalian SERPINE1 gene and the SERPIN family as key elements in the regulation of cell shape, motility, growth control and tissue invasion.
Prof. G. J. Peters
acting Head for the Laboratory Medical Oncology, VU University Medical Center, Netherlands. The major research interests of Prof. Peters include all aspects of pharmacology of anticancer agents, with emphasis on antifolates, other antimetabolites, platinum analogs, taxanes and more recently anti-signalling agents and third generation targeted-agents. The focus is on the improvement of treatment of lung, colon and pancreatic cancer, either by optimizing combinations or by identification of resistance genes.
Dr. William Chi-Shing Cho
is a Scientific Officer at the Department of Clinical Oncology in Queen Elizabeth Hospital. His main research interests focused on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), Guest Professor of many Universities and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences.
Senior Editors
Peter E. Lobie
National University of Singapore
Singapore
Editorial Board
Dario Marchetti
Baylor College of Medicine
USA
Tao Zhu
University of Science and TechnologyÂ
China
Charles F. Streckfus
University of Texas School of Dentistry
USA
Matthew Strout
Yale University School of Medicine
USA
Mira Jung
Georgetown University
USA
Nicola Normanno
INT-Fondazione Pascale
Italy
Giovanni Vitale
University of Milan
Italy
Preet M. Chaudhary
University of Southern California
USA
Scaggiante Bruna
University of Trieste
Italy
Santini Daniele
University Campus Bio-Medico
Italy
Jim Song
Penn State University College of Medicine
USA
Dennie V. Jones
University of Kentucky
USA
Des R. Richardson
University of Sydney
Australia
Guan Chen
Medical College of Wisconsin
USA
Domenico Rubello
Santa Maria Della Misericordia Hospital
Italy
Swaminathan Padmanabhan Iyer
Methodist Cancer Center
USA
Paul C. Kuo
Loyola University Medical Center
USA
Dmitry Pshezhetskiy
University of East Anglia
UK
André Stephan Bachmann
University of Hawaii
USA
Nasreen Najmunnisa
University of Florida
USA
Robert Amato
University of Texas Health Science Center
USA
Bechan Sharma
University of Allahabad
India
Liang Xu
University of Kansas
USA
Stefan Octavian Ciurea
University of Texas
USA
Vaclav Vetvicka
University of Louisville
USA
Stephen John Clarke
Royal North Shore Hospital
Australia
Barry L. Ziober
University of Pennsylvania
USA
Sundar Jagannath
Mount Sinai School of Medicine
USA
Alfons Lawen
Monash University
Australia
Sanjay Gupta
Case Western Reserve University
USA
Zeev Estrov
University of Texas
USA
Vicente Notario
Georgetown University Medical Center
USA
Ashish Saxena
University of Texas
USA
Parag P. Shah
University of Louisville
USA
François-Xavier Claret
The University of Texas MD Anderson Cancer Center
USA
Carlos Telleria
University of South Dakota
USA
Alexander Stojadinovic
Uniformed Services University of the Health Sciences
USA
Itzhak Avital
Bon Secours Cancer Institute
USA